| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | TAS1R1 GPR87 OR5AK3P OR2T10 OR2T6 OR5AK2 OR2T27 OR2AT4 PTH2R OR1A1 | 2.62e-05 | 884 | 46 | 10 | GO:0004930 |
| GeneOntologyMolecularFunction | olfactory receptor activity | 5.38e-05 | 431 | 46 | 7 | GO:0004984 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | TAS1R1 GPR87 OR5AK3P OR2T10 OR2T6 OR5AK2 OR2T27 OR2AT4 PLXNA2 PTH2R OR1A1 | 1.95e-04 | 1353 | 46 | 11 | GO:0004888 |
| GeneOntologyMolecularFunction | molecular sequestering activity | 3.40e-04 | 59 | 46 | 3 | GO:0140313 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | 1.05e-05 | 485 | 46 | 8 | GO:0050907 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | 1.83e-05 | 524 | 46 | 8 | GO:0009593 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | 2.50e-05 | 547 | 46 | 8 | GO:0007606 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | 3.88e-05 | 582 | 46 | 8 | GO:0050906 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | 4.45e-05 | 432 | 46 | 7 | GO:0050911 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | 7.08e-05 | 465 | 46 | 7 | GO:0007608 | |
| GeneOntologyBiologicalProcess | detection of stimulus | 1.74e-04 | 722 | 46 | 8 | GO:0051606 | |
| Domain | Olfact_rcpt | 3.40e-04 | 393 | 45 | 6 | IPR000725 | |
| Domain | PINT | 6.67e-04 | 16 | 45 | 2 | SM00088 | |
| Domain | PCI | 7.54e-04 | 17 | 45 | 2 | PF01399 | |
| Domain | PCI_dom | 7.54e-04 | 17 | 45 | 2 | IPR000717 | |
| Domain | GPCR_Rhodpsn_7TM | 1.03e-03 | 670 | 45 | 7 | IPR017452 | |
| Domain | 7tm_1 | 1.09e-03 | 677 | 45 | 7 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 1.17e-03 | 685 | 45 | 7 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 1.23e-03 | 691 | 45 | 7 | PS50262 | |
| Domain | GPCR_Rhodpsn | 1.24e-03 | 692 | 45 | 7 | IPR000276 | |
| Pubmed | 1.50e-05 | 36 | 46 | 3 | 22421546 | ||
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | 8.55e-05 | 340 | 46 | 5 | 11875048 | |
| Pubmed | 8.55e-05 | 340 | 46 | 5 | 11802173 | ||
| Pubmed | 8.91e-05 | 343 | 46 | 5 | 32295537 | ||
| Pubmed | 9.29e-05 | 346 | 46 | 5 | 14611657 | ||
| Pubmed | 9.34e-05 | 11 | 46 | 2 | 19812171 | ||
| Pubmed | De novo genic mutations among a Chinese autism spectrum disorder cohort. | 1.12e-04 | 12 | 46 | 2 | 27824329 | |
| Pubmed | Amyotrophic lateral sclerosis: an update on recent genetic insights. | 1.12e-04 | 12 | 46 | 2 | 24085347 | |
| Pubmed | 1.54e-04 | 14 | 46 | 2 | 19851340 | ||
| Pubmed | Spatiotemporal regulation of GLI target genes in the mammalian limb bud. | 1.64e-04 | 207 | 46 | 4 | 26238476 | |
| Pubmed | 1.78e-04 | 15 | 46 | 2 | 20215397 | ||
| Pubmed | 2.27e-04 | 89 | 46 | 3 | 24529757 | ||
| Pubmed | 3.20e-04 | 20 | 46 | 2 | 19079260 | ||
| Pubmed | 3.89e-04 | 22 | 46 | 2 | 21348951 | ||
| Pubmed | 5.21e-04 | 1431 | 46 | 8 | 37142655 | ||
| Pubmed | 6.79e-04 | 29 | 46 | 2 | 22972626 | ||
| Pubmed | 6.89e-04 | 130 | 46 | 3 | 12421765 | ||
| Pubmed | 7.24e-04 | 541 | 46 | 5 | 14983052 | ||
| Pubmed | 9.90e-04 | 35 | 46 | 2 | 24515614 | ||
| Pubmed | Global phosphoproteome analysis on human HepG2 hepatocytes using reversed-phase diagonal LC. | 1.05e-03 | 36 | 46 | 2 | 16097034 | |
| Pubmed | Identification of UHRF1/2 as new N-methylpurine DNA glycosylase-interacting proteins. | 1.17e-03 | 38 | 46 | 2 | 23537643 | |
| Pubmed | Assembly, verification, and initial annotation of the NIA mouse 7.4K cDNA clone set. | 1.19e-03 | 157 | 46 | 3 | 12466305 | |
| Cytoband | 1q44 | 1.88e-04 | 110 | 46 | 3 | 1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q44 | 2.94e-04 | 128 | 46 | 3 | chr1q44 | |
| GeneFamily | Olfactory receptors, family 2 | 9.06e-05 | 113 | 38 | 4 | 149 | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.15e-05 | 162 | 45 | 4 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Club_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.31e-05 | 165 | 45 | 4 | 1a114eacaab598f755a173a3fed842ba91f689dd | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Club_cells-Airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.31e-05 | 165 | 45 | 4 | 9cfd3c1d2c6d714fde83b90465f1f9741b0e50ce | |
| ToppCell | Control-Epithelial_airway-Club_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.48e-05 | 168 | 45 | 4 | e85bc5398eb36b2b0773a8a7082e3ba740452165 | |
| ToppCell | Control-Epithelial_airway-Club_cells-Airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.48e-05 | 168 | 45 | 4 | ce87981f4da2779de952c2e5d2bbcdabb265e705 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 2.54e-05 | 169 | 45 | 4 | 625788d86f0ceebcf2653a251db1f1a9f9746d29 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.78e-05 | 173 | 45 | 4 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.84e-05 | 174 | 45 | 4 | 271c51d220842402975d97c86c9acfdbdf62a32c | |
| ToppCell | 21-Trachea-Mesenchymal-Airway_Smooth_Muscle|Trachea / Age, Tissue, Lineage and Cell class | 3.54e-05 | 184 | 45 | 4 | 86a96cd88e50eacad1f0badfbbf6dc626f41725e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.77e-05 | 187 | 45 | 4 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.77e-05 | 187 | 45 | 4 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.77e-05 | 187 | 45 | 4 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.85e-05 | 188 | 45 | 4 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 3.93e-05 | 189 | 45 | 4 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.18e-05 | 192 | 45 | 4 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | C_06|World / shred on cell type and cluster | 4.35e-05 | 194 | 45 | 4 | 5cb42e09f380c4468cdc603ec0c3de35eadd3213 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-AT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.71e-05 | 198 | 45 | 4 | 54228dd9a50616d2022712d162a419ed0327cabd | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.71e-05 | 198 | 45 | 4 | 6483d412b6c0aab58b3348f99231caa5daf65025 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-AT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.80e-05 | 199 | 45 | 4 | aca81a879ef9c196bd1885eff4c63ffe6c9682b7 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Airway-Club|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.89e-05 | 200 | 45 | 4 | df90b67490cd649de3e3a713762ffbc34a698899 | |
| ToppCell | (08)_PNEC-(4)_1wkpi|(08)_PNEC / shred by cell type and Timepoint | 6.42e-05 | 12 | 45 | 2 | f1b105bcdbe03be6765c820b42c752a24d502212 | |
| ToppCell | TCGA-Breast-Metastatic-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.14e-04 | 93 | 45 | 3 | 504e11d516073492d6ef8cd3bd3b8a652351f2b2 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Serous_adenocarcinoma-2|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.63e-04 | 105 | 45 | 3 | 744be8b4255bef3a973db7e4306e52387852e502 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Rorb-Excitatory_Neuron.Sc17a7.Rorb-Gpr83_(Layer_5a)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.77e-04 | 108 | 45 | 3 | 5af010a1ee6535b144ccd16999c225508a4b3433 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-1|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.79e-04 | 126 | 45 | 3 | 8b689886ce35ff798aea603cde9ccb0dc9d1fd03 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.05e-04 | 143 | 45 | 3 | 27e06327f96cb72bd111ea6ece6307e5ebb3a146 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-hematopoietic_progenitor|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.05e-04 | 143 | 45 | 3 | 4edef95ae2a1ef4fc4b0d4fadf75bfc54b583932 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.38e-04 | 147 | 45 | 3 | e99197e3c2e9d63153cc55ae62b30b8363c2267e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.47e-04 | 148 | 45 | 3 | 9fe3c0a5904b8e9a0f28130f8d84d4f2a819b06c | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.47e-04 | 148 | 45 | 3 | d44f6c5fc8d1fce4046598030a48fa57ed520a6a | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.83e-04 | 152 | 45 | 3 | dbfb4d4de36ef9f5c7da1950baa915b12788685e | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.83e-04 | 152 | 45 | 3 | 9f3682da00fd627e80aa820ecc6f5fed23b9738a | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-04 | 156 | 45 | 3 | ba9dfee9373d657d2a55572b41fc62001ad8b037 | |
| ToppCell | Control-Epithelial_airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.41e-04 | 158 | 45 | 3 | 35aee1c3b92169e73569331022833cb44ab7e7e8 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-04 | 158 | 45 | 3 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-04 | 158 | 45 | 3 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | severe_influenza-cDC|World / disease group, cell group and cell class (v2) | 5.72e-04 | 161 | 45 | 3 | 802f8cafb5f499e3b2ec0193d6eb1ac9320b9287 | |
| ToppCell | LPS-IL1RA-Epithelial_airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.72e-04 | 161 | 45 | 3 | 472c354f5ee148b37a5dfb795e83348ecb1643f1 | |
| ToppCell | Influenza_Severe-Neutrophil|Influenza_Severe / Disease group and Cell class | 5.72e-04 | 161 | 45 | 3 | 98c95b1b85d5427415af2ca8fb14849e97f6e8b5 | |
| ToppCell | severe_influenza-cDC|severe_influenza / disease group, cell group and cell class (v2) | 5.72e-04 | 161 | 45 | 3 | 7716315b8bda904b346cea47edc2c0b507a345c2 | |
| ToppCell | AT1_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 5.82e-04 | 162 | 45 | 3 | ae2ba4f21f6f6c512006fa531d670b88be7c04c9 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-3|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 5.92e-04 | 163 | 45 | 3 | 0e8d3c98209fc98b86b841d69051cee9e276d837 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 6.03e-04 | 164 | 45 | 3 | de1646dbcf2a10b48e021acf7dc63e803e6a47ce | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3-5_THEMIS_ELOF1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.03e-04 | 164 | 45 | 3 | f21f7589eb185c5da208e411b4658eb9ead7bd31 | |
| ToppCell | LPS-antiTNF-Epithelial_airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.25e-04 | 166 | 45 | 3 | eb942ed68677e55c46cb039046f45686d4062d7c | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.25e-04 | 166 | 45 | 3 | 1df4bdf7c773cbfa6c93d7a901f9cd3f3fe07a3d | |
| ToppCell | Basal_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 6.25e-04 | 166 | 45 | 3 | 23c04d1fba0c1733ccd0e4378fae2edde4fd0a7b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.25e-04 | 166 | 45 | 3 | 9628522e7af8f8edca733588a364ab2454ac5ca5 | |
| ToppCell | Club_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 6.36e-04 | 167 | 45 | 3 | dbdaaeb3bd9139cb008d9fe24ec031fc5628f136 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.58e-04 | 169 | 45 | 3 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.69e-04 | 170 | 45 | 3 | 6c65ddb496030bb479ef346cc37a9d4dfa6b824f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5_RORB_LINC01202|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.69e-04 | 170 | 45 | 3 | 87cac555f16b6c2ef3d1b3a00f992d8bf2237b50 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.92e-04 | 172 | 45 | 3 | bb542f6ca4eb8167129bc84ca1160a54fbb68731 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.92e-04 | 172 | 45 | 3 | aff37b9689b0d30ee7097d997d9588efc475c8fd | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-04 | 173 | 45 | 3 | 2acd0693a2dfe04e3c1b2125ea63efe92d13150b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-04 | 173 | 45 | 3 | 2415b6ff49f334da570577d4e93484d024a3dbd5 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.16e-04 | 174 | 45 | 3 | 742c73c9e090848b464323cb17579b86658c6792 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.16e-04 | 174 | 45 | 3 | 7fed9722e64c60843092f2ba71256e3043011ef6 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.16e-04 | 174 | 45 | 3 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.16e-04 | 174 | 45 | 3 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 7.28e-04 | 175 | 45 | 3 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 7.28e-04 | 175 | 45 | 3 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | AT1_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 7.40e-04 | 176 | 45 | 3 | 4a30bb771297b30926fb98e2b5ec0dbdc46feac7 | |
| ToppCell | COPD-Epithelial-Aberrant_Basaloid|COPD / Disease state, Lineage and Cell class | 7.40e-04 | 176 | 45 | 3 | 11d867bcb4f2471b4e13a5f7dc1c24286197f26d | |
| ToppCell | AT1_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 7.52e-04 | 177 | 45 | 3 | 3128b8d04687acee1ac4190b2569d6328b98eaf3 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.52e-04 | 177 | 45 | 3 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | Control-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.65e-04 | 178 | 45 | 3 | aa7d43c655df493f1330a5001efaa484e4a19f69 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-HSC/MPP_and_pro-MEP|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.65e-04 | 178 | 45 | 3 | b8c301d65c0f37941e8e9414d55e90edb6ecc195 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.65e-04 | 178 | 45 | 3 | 1817bc520f3d23da8c0fa09bba50ae703a820cb1 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-04 | 179 | 45 | 3 | a3922476f33d2e4137a12dbda21a1703dff79684 | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 7.77e-04 | 179 | 45 | 3 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 7.77e-04 | 179 | 45 | 3 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.77e-04 | 179 | 45 | 3 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.77e-04 | 179 | 45 | 3 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.77e-04 | 179 | 45 | 3 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.77e-04 | 179 | 45 | 3 | b8ca29aebd25ebac441bebd769bbf98c536d3166 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.90e-04 | 180 | 45 | 3 | e9785ac2806103f725f5a5208495826354ec6e22 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.02e-04 | 181 | 45 | 3 | fb4df9a128761abe5c6310a30d7b2f7f2fdef46d | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.15e-04 | 182 | 45 | 3 | fa23d5bed1147a423c42bd30029a06963410b16e | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.28e-04 | 183 | 45 | 3 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.28e-04 | 183 | 45 | 3 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial-neuroendocrine_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.42e-04 | 184 | 45 | 3 | e0e5a553fb8c0947679634396d20c2ca8455b932 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.42e-04 | 184 | 45 | 3 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial-neuroendocrine_cell-neuroendocrine|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.42e-04 | 184 | 45 | 3 | c3b848e1438a84b3fac8a4e40f3db478cc84d970 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.42e-04 | 184 | 45 | 3 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | droplet-Skin|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-04 | 185 | 45 | 3 | 657fd191ed160f8620d57b33820ec7222806f289 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.55e-04 | 185 | 45 | 3 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-lung_neuroendocrine_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-04 | 185 | 45 | 3 | 30263c558ee331e0879abcf8b4c2427ff05f9fe7 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.55e-04 | 185 | 45 | 3 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.55e-04 | 185 | 45 | 3 | 7bff05d8d34616adbaa0ea0b69eb30aa906bb9f8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.55e-04 | 185 | 45 | 3 | 4d0f3d86fab02c80093e62cb0c79c586c13c5412 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-Neuroendocrine|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-04 | 185 | 45 | 3 | 1b000ca11970db8f347eb97ff44605d562aea70a | |
| ToppCell | saliva-Severe-critical_progression_d28-40|saliva / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.68e-04 | 186 | 45 | 3 | 0095560ca776b01aa473ad4d6015ed78fc93ff51 | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.68e-04 | 186 | 45 | 3 | 37b93ebd64ebbd08193a746e5bc9b350c2570733 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 8.68e-04 | 186 | 45 | 3 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | PCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_ErythroMeg|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.68e-04 | 186 | 45 | 3 | 3b60a153e6cfc1b977a1f8b8f3bcaf75d1f4ff5b | |
| ToppCell | PCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-erythro|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.68e-04 | 186 | 45 | 3 | 6078aa16261554c7fd41137b8de1362d15b30490 | |
| ToppCell | Influenza-Influenza_Severe-Myeloid-Neutrophil|Influenza_Severe / Disease, condition lineage and cell class | 8.68e-04 | 186 | 45 | 3 | 1dfcec9196d4db76fba3abc74e85885b1fb98b87 | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.68e-04 | 186 | 45 | 3 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | PCW_07-8.5-Hematologic_ErythroMegGranulo|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.68e-04 | 186 | 45 | 3 | 294839944266407c40ef86e1d3e0fce4652b70ff | |
| Disease | unipolar depression, smoking behaviour measurement | 1.30e-05 | 4 | 44 | 2 | EFO_0003761, EFO_0005671 | |
| Disease | Neurodevelopmental Disorders | 3.66e-04 | 93 | 44 | 3 | C1535926 | |
| Disease | response to antiviral drug, cirrhosis of liver | 5.87e-04 | 24 | 44 | 2 | EFO_0001422, EFO_0010123 | |
| Disease | serum IgA measurement | 9.83e-04 | 31 | 44 | 2 | EFO_0004912 | |
| Disease | obese body mass index status | 1.11e-03 | 33 | 44 | 2 | EFO_0007041 | |
| Disease | cardiac hypertrophy | 1.25e-03 | 35 | 44 | 2 | EFO_0002503 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DYFIYSQVTFRGMTS | 146 | O95150 | |
| QYISEYMQSDSIRSY | 1016 | Q9UMD9 | |
| TTMGVNTYKARIQYY | 391 | P00736 | |
| YVTLCSNGMLTYYSS | 281 | Q5VW22 | |
| NEQYGAVRTPYTMSY | 191 | Q9BWF3 | |
| RYRTITTAYYRGAMG | 91 | Q96E17 | |
| YLTGMLSSYYNTTSV | 181 | Q9BWQ8 | |
| YAGRSSSRYMVYDVV | 131 | Q9NVR5 | |
| MFRYNEENYGVVSTY | 401 | Q99700 | |
| RMTSVASYVYNGYSV | 431 | O75051 | |
| QYYERTVTVPMYSSQ | 361 | O43526 | |
| MVVTLFYGAALYTYT | 246 | Q8NHC8 | |
| ETLSYSYCYVGIMTG | 151 | Q96N66 | |
| IANASGYMYETSYRR | 181 | Q9UL01 | |
| VVVSLFYGAAMYTYV | 246 | Q8NH04 | |
| YTSVLFYANMYTSIV | 116 | Q9BY21 | |
| TAVTIFYGTLSYMYL | 246 | Q8NH89 | |
| TVVSLFYGAAIYNYM | 246 | Q8NGZ9 | |
| ALCAYAVTYTAMYVT | 211 | Q96GM1 | |
| TAVTIFYGTLSYMYL | 246 | Q8NH90 | |
| MAAQGYGYYRTVIFS | 1 | O43826 | |
| TYLFTYSSVYDSISM | 791 | B5ME19 | |
| SCIYYETTMSNRGSY | 941 | Q8N6C5 | |
| MSFTAGSYSSYVQVR | 311 | Q92562 | |
| EYSTQSYTGYEPTSM | 121 | Q9H9T3 | |
| VASYNMGSNSIYYFR | 56 | Q15828 | |
| YYVTYSSMIYRQQQS | 151 | Q92913 | |
| VGFYRTQYSSAMLES | 586 | P55786 | |
| MSSSYYVNALFSKYT | 1 | P31268 | |
| YKTFVTYTVYVSMIA | 216 | Q15008 | |
| VRTSQMAYNSIAYIY | 166 | A6NND4 | |
| VVSLYYGTVMGTYFR | 246 | Q9P1Q5 | |
| AQYMGSGYTKAVYRV | 141 | Q504Y2 | |
| MQYSARGSQSYYTVA | 691 | P51531 | |
| YGTHYSSAMIVASYL | 2786 | Q8IZQ1 | |
| FSMSSAYNAYRAVYA | 381 | Q7RTX1 | |
| YSVTMAARIAYSSYI | 126 | P41440 | |
| YYVSSTVAYAIGMIL | 436 | Q8TCT8 | |
| YARNITSTDSSYQMY | 861 | Q8NB14 | |
| FERLYVMYTVGYSIS | 141 | P49190 | |
| SYQSYQSPTMREEYA | 106 | Q96JE7 | |
| TVMYYGFYTNSTIQH | 501 | Q6UXY8 | |
| YTSYSVQTMETVPYQ | 426 | P57082 | |
| MTGREQKVYYSYSQI | 271 | Q9UBB9 | |
| YTMTSVLQQLSYFYT | 1546 | Q9NQX4 | |
| YVTTLTEMYTNQDRY | 1151 | Q9UL68 |